The Cancer Letter

Inside information on cancer research and drug development

Vol.
27
No.
46
December 14, 2001Dec 14, 2001
Free
DOWNLOAD THE PDF

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

Campus-Dweller Rabson Finds Comfort In NIH Security.

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

Myriad In Partnership To Market Products.

Computer-Aided Detection Approved For Mammograms.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account